MAPT and Alzheimer disease: The relationship between GSK3 and p‐tau is most widely reported, with various AD‐related pathologies such as Aβ or signaling pathways such as PI3K/AKT signaling and AMPK signaling ultimately leading to GSK3‐mediated tau hyperphosphorylation (Figure 3).